Antiphospholipid antibodies in pregnancy: clinical associations.
Antiphospholipid antibodies are a group of pathogenic antibodies associated with adverse pregnancy outcome. Pregnancies complicated by the presence of antibodies require careful surveillance and in specific situations therapy with low-dose aspirin, corticosteroids and/or heparin.
Birdsall
M A
MA
Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.
Pattison
N S
NS
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D001241:Aspirin / Q000627:therapeutic use; D002985:Clinical Protocols; D003663:Decision Trees; D004359:Drug Therapy, Combination; D005260:Female; D005323:Fetal Monitoring; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011256:Pregnancy Outcome; D015995:Prevalence; D013921:Thrombocytopenia / Q000209:etiology; D013927:Thrombosis / Q000209:etiology
D000305:Adrenal Cortex Hormones; D006493:Heparin; D001241:Aspirin